Joshua Nair is a driven Principal Administrative Business Partner and Operations Manager at Genentech, with over a decade of ...

The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...

Wafaa Mamilli will join Roche as the company's new Chief Digital Technology Officer in February. This follows expansive roles ...

It also comes after a pledge by the company to plough savings from a cost-reduction drive back into its pipeline. The three platform deals are long-term bets, but broaden Genentech’s drug ...

Genentech Genentech’s most recent layoffs mark the company’s second of the year. In April, Genentech cut 436 jobs at its South SF office. The biotech firm also has offices in Vacaville ...

Genentech, a member of Roche (RHHBY), announced topline results from the overall survival analysis of the Phase III INAVO120 study ...

and is coming up to a two-decade anniversary at the Roche/Genentech group. She also took control of the company during Hardy’s recent sabbatical, a longstanding policy at the biotech unit that ...

On December 6, 1994, outside of the South San Francisco headquarters of a biotechnology company called Genentech, a group of protestors shouted, honked, waved signs, and laid out on the street.

Genentech is a biotech company. Right now it's working on a drug to prevent the onset of Alzheimer's. In 2008, Genentech's lobbying firm successfully convinced several Congressional reps to use ...

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics ...